IDYA IDEAYA Biosciences, Inc.

Fundamentals / CIK 0001676725 / USD

IDEAYA Biosciences, Inc. reported $218.7M in revenue and a net loss of $420.0M for the fiscal year ended December 31, 2025 (up 3024.4% year over year), with a -211.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open IDYA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2017 to 2025), reported in USD.

$244.5M$122.3M$0-$275.2MFY 2017 Net Income: -$11.86M2017FY 2018 Net Income: -$34.35M2018FY 2019 Revenue: $0FY 2019 Net Income: -$41.98M2019FY 2020 Revenue: $19.54MFY 2020 Net Income: -$34.49M2020FY 2021 Revenue: $27.94MFY 2021 Net Income: -$49.76M2021FY 2022 Revenue: $50.93MFY 2022 Net Income: -$58.66M2022FY 2023 Revenue: $23.39MFY 2023 Net Income: -$113.0M2023FY 2024 Revenue: $7.00MFY 2024 Net Income: -$274.5M2024FY 2025 Revenue: $218.7MFY 2025 Net Income: -$113.7M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $218.7M $7.00M $23.39M $50.93M $27.94M $19.54M $0 -- --
Research & Development $314.7M $294.7M $129.5M $89.54M $58.16M $39.70M $34.32M $31.75M $12.38M
Total Operating Expenses $378.0M $334.0M $157.8M $113.4M $78.21M $54.88M $44.27M $36.42M $14.44M
Operating Income -$159.3M -$327.0M -$134.4M -$62.50M -$50.27M -$35.34M -$44.27M -$36.42M -$14.44M
EBITDA -$156.6M -$324.6M -$132.0M -$60.40M -$48.54M -$33.96M -$43.03M -$35.53M -$14.05M
Interest Income -- -- -- -- -- -- $2.29M $1.99M $150K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 --
Net Income -$113.7M -$274.5M -$113.0M -$58.66M -$49.76M -$34.49M -$41.98M -$34.35M -$11.86M
Basic EPS -$1.28 -$3.36 -$1.96 -$1.42 -$1.41 -$1.40 -$3.36 -$35.92 -$17.06
Diluted EPS -$1.28 -$3.36 -$1.96 -$1.42 -$1.41 -$1.40 -$3.36 -$35.92 -$17.06
Basic Shares Outstanding 88.5M 81.7M 57.5M 41.4M 35.3M 24.7M 12.5M 956.3K 695.4K
Diluted Shares Outstanding 88.5M 81.7M 57.5M 41.4M 35.3M 24.7M 12.5M 956.3K 695.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $10.24M $8.86M $6.56M -- $207.8M -- -- $7.00M
Research & Development $121.6M $82.99M $95.73M $86.60M $82.99M $74.23M $70.89M $140.2M
Total Operating Expenses $147.9M $131.1M $115.1M $105.4M $99.38M $88.81M $84.39M $151.1M
Operating Income -$137.6M -$122.3M -$108.5M -$94.57M $108.5M -$88.81M -$84.39M -$144.1M
EBITDA -$137.0M -$121.6M -$107.9M -$93.85M $109.1M -$88.09M -$83.79M -$143.6M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$125.7M -$112.5M -$98.54M -$83.27M $119.2M -$77.49M -$72.18M -$130.3M
Basic EPS -$1.22 -$1.22 -$1.11 -- $1.35 -$0.88 -$0.82 --
Diluted EPS -$1.22 -$1.22 -$1.11 -- $1.33 -$0.88 -$0.82 --
Basic Shares Outstanding 102.9M 92.1M 88.7M -- 88.5M 88.5M 88.4M --
Diluted Shares Outstanding 102.9M 92.1M 88.7M -- 89.7M 88.5M 88.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $112.8M $84.38M $157.0M $68.63M $92.05M $72.04M $34.07M $20.50M
Short-Term Investments $526.6M $591.9M $368.1M $296.2M $154.7M $211.5M $64.89M $69.46M
Cash & Short-Term Investments $639.4M $676.3M $525.1M $364.8M $246.8M $283.6M $98.96M $89.96M
Accounts Receivable, Net -- $3.0K $18K $211K $1.10M $1.88M -- --
Total Current Assets $666.7M $689.7M $532.6M $370.5M $251.0M $288.6M $101.7M $90.67M
Property, Plant & Equipment, Net $8.22M $8.97M $6.16M $6.51M $4.76M $4.27M $4.64M $5.15M
Long-Term Investments $410.3M $405.8M $107.5M $8.32M $121.3M $0 $1.53M --
Other Non-Current Assets $126K -- $25K $99K $291K $82K $16K $46K
Total Non-Current Assets $442.6M $434.4M $116.7M $17.52M $130.4M $9.66M $11.35M $5.87M
Total Assets $1.11B $1.12B $649.3M $388.0M $381.3M $298.3M $113.0M $96.54M
Accounts Payable $17.58M $15.42M $6.60M $4.28M $2.10M $953K $709K $1.42M
Deferred Revenue (Current) -- -- -- $8.57M $29.04M $27.61M -- --
Other Current Liabilities -- -- -- -- -- $18K $63K $114K
Total Current Liabilities $58.81M $46.07M $27.10M $31.72M $45.16M $38.64M $6.94M $5.41M
Deferred Revenue (Non-Current) -- -- -- $5.18M $31.19M $56.16M -- --
Other Non-Current Liabilities -- -- -- -- -- $12K $34K $113K
Total Non-Current Liabilities $27.57M $18.87M $1.12M $6.80M $34.67M $61.35M $5.66M $1.69M
Total Liabilities $86.39M $64.94M $28.23M $38.51M $79.83M $100.00M $12.60M $7.10M
Total Debt (incl. Leases) $27.91M $19.17M $2.87M $3.48M $5.18M $6.72M $6.77M --
Common Stock $9.0K $9.0K $7.0K $5.0K $4.0K $3.0K $2.0K --
Retained Earnings -$736.5M -$622.8M -$348.4M -$235.4M -$176.7M -$127.0M -$92.49M -$50.52M
Accumulated Other Comp. Income $2.27M $812K $562K -$2.87M -$712K $7.0K $65K -$31K
Total Stockholders' Equity $1.02B $1.06B $621.1M $349.5M $301.5M $198.3M $100.4M -$48.95M
Total Equity $1.02B $1.06B $621.1M $349.5M $301.5M $198.3M $100.4M -$48.95M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $261.5M $272.6M $157.5M $112.8M $298.9M $114.6M $130.0M $84.38M
Short-Term Investments $577.1M $556.4M $513.7M $526.6M $488.0M $555.1M $562.5M $591.9M
Cash & Short-Term Investments $838.5M $829.0M $671.2M $639.4M $786.9M $669.7M $692.5M $676.3M
Accounts Receivable, Net -- -- -- -- -- -- -- $3.0K
Total Current Assets $872.0M $864.0M $696.1M $666.7M $802.7M $685.6M $707.9M $689.7M
Property, Plant & Equipment, Net $7.94M $8.28M $8.63M $8.22M $8.17M $8.82M $8.87M $8.97M
Long-Term Investments $312.3M $413.9M $301.7M $410.3M $350.0M $322.1M $358.7M $405.8M
Other Non-Current Assets $909K -- -- $126K -- -- -- --
Total Non-Current Assets $344.1M $445.7M $334.2M $442.6M $382.5M $355.7M $392.8M $434.4M
Total Assets $1.22B $1.31B $1.03B $1.11B $1.19B $1.04B $1.10B $1.12B
Accounts Payable $22.04M $30.51M $20.74M $17.58M $18.43M $17.27M $17.63M $15.42M
Deferred Revenue (Current) -- -- -- -- $490K -- -- --
Total Current Liabilities $96.41M $82.68M $64.83M $58.81M $64.51M $55.34M $50.85M $46.07M
Deferred Revenue (Non-Current) -- -- -- -- $1.68M -- -- --
Total Non-Current Liabilities $27.55M $28.12M $28.25M $27.57M $28.59M $26.28M $25.66M $18.87M
Total Liabilities $124.0M $110.8M $93.08M $86.39M $93.10M $81.62M $76.51M $64.94M
Total Debt (incl. Leases) $29.70M $29.31M $28.60M $27.91M $27.25M $26.60M $25.97M $19.17M
Common Stock $10K $10K $9.0K $9.0K $9.0K $9.0K $9.0K $9.0K
Retained Earnings -$1.07B -$947.5M -$835.1M -$736.5M -$653.3M -$772.5M -$695.0M -$622.8M
Accumulated Other Comp. Income -$4.88M -$1.67M -$494K $2.27M $2.05M $1.52M $1.58M $812K
Total Stockholders' Equity $1.09B $1.20B $937.3M $1.02B $1.09B $959.7M $1.02B $1.06B
Total Equity $1.09B $1.20B $937.3M $1.02B $1.09B $959.7M $1.02B $1.06B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$113.7M -$274.5M -$113.0M -$58.66M -$49.76M -$34.49M -$41.98M -$34.35M -$11.86M
Depreciation & Amortization $2.70M $2.39M $2.48M $2.10M $1.73M $1.38M $1.25M $886K $391K
Stock-Based Compensation $46.12M $34.75M $18.49M $11.63M $8.24M $3.61M $2.17M $950K $136K
Change in Receivables $0 $0 $193K $892K $774K -$1.88M $0 -- --
Change in Payables $2.70M $8.28M $2.63M $1.86M $1.17M $225K -$195K $322K $254K
Operating Cash Flow -$71.10M -$247.6M -$115.2M -$87.17M -$55.78M $55.46M -$39.31M -$27.62M -$12.22M
Capital Expenditure -$2.37M -$3.86M -$2.37M -$3.44M -$2.64M -$493K -$1.35M -$1.71M -$1.76M
Free Cash Flow -$73.47M -$251.4M -$117.6M -$90.62M -$58.42M $54.97M -$40.67M -$29.33M -$13.98M
Purchases of Investments -$607.9M -$1.19B -$596.0M -$255.8M -$315.0M -$242.3M -$88.00M -$133.3M -$13.47M
Sales & Maturities of Investments -- -- $439.9M $225.8M $248.0M -- -- -- --
Investing Cash Flow $69.98M -$502.6M -$158.5M -$33.40M -$69.67M -$146.2M $2.27M -$63.18M -$8.93M
Common Stock Issued $0 $274.4M $281.2M $86.11M $85.99M $100.7M $50.32M -- --
Financing Cash Flow $29.78M $677.6M $362.7M $97.17M $145.5M $128.8M $50.61M $105.4M $17.49M
Net Change in Cash $28.66M -$72.59M $89.04M -$23.41M $20.01M $37.97M $13.56M $14.58M -$3.66M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$125.7M -$112.5M -$98.54M -$83.27M $119.2M -$77.49M -$72.18M -$130.3M
Depreciation & Amortization $614K $688K $688K $721K $661K $718K $600K $572K
Stock-Based Compensation $17.73M $16.66M $14.54M $11.79M $12.22M $11.87M $10.24M $9.48M
Change in Receivables -- -- -- -- -- -- -- $2.0K
Change in Payables -$7.50M $8.89M $3.05M -$858K $1.19M -$364K $2.73M $2.98M
Operating Cash Flow -$93.48M -$88.21M -$75.17M -$90.50M $142.2M -$62.47M -$60.34M -$121.7M
Capital Expenditure -$273K -$866K -$967K -$333K -$42K -$663K -$1.33M -$1.10M
Free Cash Flow -$93.75M -$89.08M -$76.14M -$90.83M $142.2M -$63.14M -$61.67M -$122.8M
Purchases of Investments -$63.37M -$313.4M -$42.61M -$236.1M -$139.0M -$127.6M -$105.2M -$337.0M
Investing Cash Flow $78.65M -$155.9M $119.0M -$97.53M $41.77M $45.92M $79.82M -$197.1M
Common Stock Issued -- -- -- -- -- -- -- -$340K
Financing Cash Flow $3.69M $359.2M $1.18M $2.13M $301K $1.21M $26.14M $2.75M
Net Change in Cash -$11.14M $115.1M $44.96M -$185.9M $184.3M -$15.35M $45.62M -$316.0M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -72.8% -4671.1% -574.9% -122.7% -179.9% -180.9% -- -- --
Net Profit Margin -52.0% -3921.1% -483.0% -115.2% -178.1% -176.6% -- -- --
Return on Equity (ROE) -11.1% -25.9% -18.2% -16.8% -16.5% -17.4% -41.8% -- --
Return on Assets (ROA) -10.2% -24.4% -17.4% -15.1% -13.0% -11.6% -37.1% -35.6% --
Current Ratio 11.34x 14.97x 19.65x 11.68x 5.56x 7.47x 14.65x 16.75x --
Quick Ratio 10.87x 14.68x 19.38x 11.51x 5.49x 7.39x 14.26x 16.62x --
Debt to Equity 0.03x 0.02x 0.00x 0.01x 0.02x 0.03x 0.07x -- --
Revenue Growth (YoY) +3024.4% -70.1% -54.1% +82.3% +43.0% -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -200.6% -- -- -- --
Free Cash Flow Growth (YoY) -- -- -- -- -206.3% -- -- -- --
5Y Revenue / Share Growth +212.8% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -- -- -- -- -4671.1%
Net Profit Margin -- -- -- -- -- -- -- -3921.1%
Return on Equity (ROE) -38.5% -14.6% -14.9% -11.1% -14.7% -34.6% -30.0% -25.9%
Return on Assets (ROA) -34.5% -13.4% -13.6% -10.2% -13.6% -31.9% -27.9% -24.4%
Current Ratio 9.04x 10.45x 10.74x 11.34x 12.44x 12.39x 13.92x 14.97x
Quick Ratio 8.70x 10.03x 10.35x 10.87x 12.20x 12.10x 13.62x 14.68x
Debt to Equity 0.03x 0.02x 0.03x 0.03x 0.02x 0.03x 0.03x 0.02x
Revenue Growth (YoY) -95.1% -- -- -- -- -- -- +78.5%
Operating Income Growth (YoY) -226.9% -- -- -- -- -- -- --
Net Income Growth (YoY) -205.5% -- -- -- -- -- -- --
EPS Growth (YoY) -190.4% -- -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -165.7% -- -- -- -- -- -- --
Free Cash Flow Growth (YoY) -165.9% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001676725) · from December 31, 2017 Data through September 30, 2026 · synced Nov 20, 2026, 05:20 UTC · Open in terminal